XML 42 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value (Tables)
9 Months Ended
Sep. 30, 2013
Fair Value Disclosures [Abstract]  
Recurring Fair Value Measurements
The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy, including those items for which the Company has elected the FVO, are presented below.
 
September 30, 2013
 
Fair Value Hierarchy
 
 
 
Level 1
 
Level 2
 
Level 3
 
Total Estimated
Fair Value
 
(In millions)
Assets:
 
 
 
 
 
 
 
Fixed maturity securities:
 
 
 
 
 
 
 
U.S. corporate
$

 
$
101,605

 
$
5,886

 
$
107,491

Foreign corporate

 
57,384

 
6,264

 
63,648

Foreign government

 
50,941

 
2,063

 
53,004

U.S. Treasury and agency
23,460

 
20,629

 
65

 
44,154

RMBS
657

 
31,803

 
3,018

 
35,478

CMBS

 
15,720

 
1,176

 
16,896

ABS

 
10,098

 
4,063

 
14,161

State and political subdivision

 
13,939

 
16

 
13,955

Total fixed maturity securities
24,117

 
302,119

 
22,551

 
348,787

Equity securities:
 
 
 
 
 
 
 
Common stock
1,102

 
983

 
185

 
2,270

Non-redeemable preferred stock

 
566

 
405

 
971

Total equity securities
1,102

 
1,549

 
590

 
3,241

FVO and trading securities:
 
 
 
 
 
 
 
Actively Traded Securities
4

 
621

 
11

 
636

FVO general account securities
5

 
139

 
47

 
191

FVO contractholder-directed unit-linked investments
10,302

 
4,888

 
606

 
15,796

FVO securities held by CSEs

 
23

 

 
23

Total FVO and trading securities
10,311

 
5,671

 
664

 
16,646

Short-term investments (1)
3,615

 
6,799

 
192

 
10,606

Mortgage loans:
 
 
 
 
 
 
 
Residential mortgage loans — FVO

 

 
212

 
212

Commercial mortgage loans held by CSEs

 
2,096

 

 
2,096

Mortgage loans held-for-sale (2)

 

 

 

Total mortgage loans

 
2,096

 
212

 
2,308

Other invested assets:
 
 
 
 
 
 

Other investments
161

 
78

 

 
239

Derivative assets: (3)
 
 
 
 
 
 


Interest rate
3

 
6,206

 
64

 
6,273

Foreign currency exchange rate
2

 
995

 
25

 
1,022

Credit

 
98

 
31

 
129

Equity market
30

 
1,543

 
304

 
1,877

Total derivative assets
35

 
8,842

 
424

 
9,301

Total other invested assets
196

 
8,920

 
424

 
9,540

Net embedded derivatives within asset host contracts (4)

 

 
322

 
322

Separate account assets (5)
35,689

 
218,144

 
1,417

 
255,250

Total assets
$
75,030

 
$
545,298

 
$
26,372

 
$
646,700

Liabilities:
 
 
 
 
 
 
 
Derivative liabilities: (3)
 
 
 
 
 
 
 
Interest rate
$
7

 
$
2,457

 
$
19

 
$
2,483

Foreign currency exchange rate

 
1,542

 
16

 
1,558

Credit

 
40

 

 
40

Equity market
4

 
918

 
555

 
1,477

Total derivative liabilities
11

 
4,957

 
590

 
5,558

Net embedded derivatives within liability host contracts (4)

 
7

 
375

 
382

Long-term debt of CSEs

 
1,920

 
26

 
1,946

Trading liabilities (6)
228

 
4

 

 
232

Total liabilities
$
239

 
$
6,888

 
$
991

 
$
8,118

 
December 31, 2012
 
Fair Value Hierarchy
 
 
 
Level 1
 
Level 2
 
Level 3
 
Total Estimated
Fair Value
 
(In millions)
Assets:
 
 
 
 
 
 
 
Fixed maturity securities:
 
 
 
 
 
 
 
U.S. corporate
$

 
$
106,693

 
$
7,433

 
$
114,126

Foreign corporate

 
60,976

 
6,208

 
67,184

Foreign government

 
55,522

 
1,814

 
57,336

U.S. Treasury and agency
27,441

 
20,455

 
71

 
47,967

RMBS

 
35,442

 
2,037

 
37,479

CMBS

 
17,982

 
1,147

 
19,129

ABS

 
12,341

 
3,656

 
15,997

State and political subdivision

 
14,994

 
54

 
15,048

Total fixed maturity securities
27,441

 
324,405

 
22,420

 
374,266

Equity securities:
 
 
 
 
 
 
 
Common stock
932

 
1,040

 
190

 
2,162

Non-redeemable preferred stock

 
310

 
419

 
729

Total equity securities
932

 
1,350

 
609

 
2,891

FVO and trading securities:
 
 
 
 
 
 
 
Actively Traded Securities
7

 
646

 
6

 
659

FVO general account securities

 
151

 
32

 
183

FVO contractholder-directed unit-linked investments
9,103

 
5,425

 
937

 
15,465

FVO securities held by CSEs

 
41

 

 
41

Total FVO and trading securities
9,110

 
6,263

 
975

 
16,348

Short-term investments (1)
9,426

 
6,295

 
429

 
16,150

Mortgage loans:
 
 
 
 
 
 
 
Residential mortgage loans — FVO

 

 

 

Commercial mortgage loans held by CSEs

 
2,666

 

 
2,666

Mortgage loans held-for-sale (2)

 

 
49

 
49

Total mortgage loans

 
2,666

 
49

 
2,715

Other invested assets:
 
 
 
 
 
 
 
Other investments
303

 
123

 

 
426

Derivative assets: (3)
 
 
 
 
 
 
 
Interest rate
1

 
9,648

 
206

 
9,855

Foreign currency exchange rate
4

 
819

 
44

 
867

Credit

 
47

 
43

 
90

Equity market
14

 
2,478

 
473

 
2,965

Total derivative assets
19

 
12,992

 
766

 
13,777

Total other invested assets
322

 
13,115

 
766

 
14,203

Net embedded derivatives within asset host contracts (4)

 
1

 
505

 
506

Separate account assets (5)
31,620

 
202,568

 
1,205

 
235,393

Total assets
$
78,851

 
$
556,663

 
$
26,958

 
$
662,472

Liabilities:
 
 
 
 
 
 
 
Derivative liabilities: (3)
 
 
 
 
 
 
 
Interest rate
$
38

 
$
3,001

 
$
29

 
$
3,068

Foreign currency exchange rate

 
1,521

 
7

 
1,528

Credit

 
39

 

 
39

Equity market
132

 
424

 
345

 
901

Total derivative liabilities
170

 
4,985

 
381

 
5,536

Net embedded derivatives within liability host contracts (4)

 
17

 
3,667

 
3,684

Long-term debt of CSEs

 
2,483

 
44

 
2,527

Trading liabilities (6)
163

 

 

 
163

Total liabilities
$
333

 
$
7,485

 
$
4,092

 
$
11,910

__________________
(1)
Short-term investments as presented in the tables above differ from the amounts presented in the consolidated balance sheets because certain short-term investments are not measured at estimated fair value on a recurring basis.
(2)
See “— Fair Value Option” for additional information on mortgage loans held-for-sale. The amounts in the preceding tables differ from the amounts presented in the consolidated balance sheets as these tables do not include mortgage loans that are stated at lower of amortized cost or estimated fair value.
(3)
Derivative assets are presented within other invested assets in the consolidated balance sheets and derivative liabilities are presented within other liabilities in the consolidated balance sheets. The amounts are presented gross in the tables above to reflect the presentation in the consolidated balance sheets, but are presented net for purposes of the rollforward in the Fair Value Measurements Using Significant Unobservable Inputs (Level 3) tables.
(4)
Net embedded derivatives within asset host contracts are presented primarily within premiums, reinsurance and other receivables in the consolidated balance sheets. Net embedded derivatives within liability host contracts are presented primarily within PABs in the consolidated balance sheets. At September 30, 2013 and December 31, 2012, equity securities also included embedded derivatives of ($136) million and ($88) million, respectively.
(5)
Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders whose liability is reflected within separate account liabilities. Separate account liabilities are set equal to the estimated fair value of separate account assets.
(6)
Trading liabilities are presented within other liabilities in the consolidated balance sheets.
Fair Value Inputs, Quantitative Information
The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at:
 
 
 
 
 
 
 
September 30, 2013
 
December 31, 2012
 
Impact of
Increase in Input
on Estimated
Fair Value (2)
 
Valuation
Techniques
 
Significant
Unobservable Inputs
 
Range
 
Weighted
Average (1)
 
Range
 
Weighted
Average (1)
 
Fixed maturity securities: (3)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. corporate and foreign corporate
Matrix pricing
 
Delta spread adjustments (4)
 
(40)
-
240
 
66
 
(50)
-
500
 
90
 
Decrease
 
 
 
 
Illiquidity premium (4)
 
30
-
30
 
30
 
30
-
30
 
30
 
Decrease
 
 
 
 
Credit spreads (4)
 
(1,508)
-
711
 
195
 
(1,416)
-
876
 
272
 
Decrease
 
 
 
 
Offered quotes (5)
 
-
134
 
101
 
-
348
 
115
 
Increase
 
Consensus pricing
 
Offered quotes (5)
 
56
-
116
 
92
 
-
555
 
92
 
Increase
Foreign government
Matrix pricing
 
Credit spreads (4)
 
9
-
1,434
 
490
 
(58)
-
150
 
72
 
Decrease
 
Market pricing
 
Quoted prices (5)
 
62
-
157
 
98
 
77
-
146
 
99
 
Increase
 
Consensus pricing
 
Offered quotes (5)
 
90
-
152
 
112
 
82
-
200
 
117
 
Increase
RMBS
Matrix pricing and discounted cash flow
 
Credit spreads (4)
 
(205)
-
3,662
 
295
 
9
-
2,980
 
521
 
Decrease (6)
 
Market pricing
 
Quoted prices (5)
 
22
-
100
 
97
 
13
-
109
 
100
 
Increase (6)
 
Consensus pricing
 
Offered quotes (5)
 
37
-
100
 
90
 
28
-
100
 
75
 
Increase (6)
CMBS
Matrix pricing and discounted cash flow
 
Credit spreads (4)
 
130
-
2,515
 
349
 
1
-
9,164
 
374
 
Decrease (6)
 
Market pricing
 
Quoted prices (5)
 
75
-
104
 
99
 
1
-
106
 
99
 
Increase (6)
 
Consensus pricing
 
Offered quotes (5)
 
96
-
96
 
96
 
 
 
 
 
 
 
Increase (6)
ABS
Matrix pricing and discounted cash flow
 
Credit spreads (4)
 
30
-
1,877
 
129
 
-
1,829
 
109
 
Decrease (6)
 
Market pricing
 
Quoted prices (5)
 
-
107
 
101
 
40
-
105
 
100
 
Increase (6)
 
Consensus pricing
 
Offered quotes (5)
 
-
106
 
89
 
-
111
 
97
 
Increase (6)
Derivatives:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate
Present value techniques
 
Swap yield (7)
 
247
-
427
 
 
 
186
-
353
 
 
 
Increase (12)
Foreign currency exchange rate
Present value techniques
 
Swap yield (7)
 
193
-
769
 
 
 
228
-
795
 
 
 
Increase (12)
 
 
 
 
Correlation (8)
 
38%
-
49%
 
 
 
43%
-
57%
 
 
 
 
Credit
Present value techniques
 
Credit spreads (9)
 
99
-
100
 
 
 
100
-
100
 
 
 
Decrease (9)
 
Consensus pricing
 
Offered quotes (10)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity market
Present value techniques or option pricing models
 
Volatility (11)
 
14%
-
29%
 
 
 
13%
-
32%
 
 
 
Increase (12)
 
 
 
 
Correlation (8)
 
60%
-
60%
 
 
 
65%
-
65%
 
 
 
 
Embedded derivatives:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Direct and assumed guaranteed minimum benefits
Option pricing techniques
 
Mortality rates:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ages 0 - 40
 
0%
-
0.14%
 
 
 
0%
-
0.14%
 
 
 
Decrease (13)
 
 
 
 
 
Ages 41 - 60
 
0.04%
-
0.88%
 
 
 
0.05%
-
0.88%
 
 
 
Decrease (13)
 
 
 
 
 
Ages 61 - 115
 
0.26%
-
100%
 
 
 
0.26%
-
100%
 
 
 
Decrease (13)
 
 
 
 
Lapse rates:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Durations 1 - 10
 
0.50%
-
100%
 
 
 
0.50%
-
100%
 
 
 
Decrease (14)
 
 
 
 
 
Durations 11 - 20
 
2%
-
100%
 
 
 
2%
-
100%
 
 
 
Decrease (14)
 
 
 
 
 
Durations 21 - 116
 
2%
-
100%
 
 
 
2%
-
100%
 
 
 
Decrease (14)
 
 
 
 
Utilization rates
 
20%
-
50%
 
 
 
20%
-
50%
 
 
 
Increase (15)
 
 
 
 
Withdrawal rates
 
0%
-
20%
 
 
 
0.07%
-
20%
 
 
 
(16)
 
 
 
 
Long-term equity volatilities
 
15.20%
-
40%
 
 
 
15.18%
-
40%
 
 
 
Increase (17)
 
 
 
 
Nonperformance risk spread
 
(0.19)%
-
1.01%
 
 
 
0.10%
-
1.72%
 
 
 
Decrease (18)
__________________
(1)
The weighted average for fixed maturity securities is determined based on the estimated fair value of the securities.
(2)
The impact of a decrease in input would have the opposite impact on the estimated fair value. For embedded derivatives, changes are based on liability positions.
(3)
Significant increases (decreases) in expected default rates in isolation would result in substantially lower (higher) valuations.
(4)
Range and weighted average are presented in basis points.
(5)
Range and weighted average are presented in accordance with the market convention for fixed maturity securities of dollars per hundred dollars of par.
(6)
Changes in the assumptions used for the probability of default is accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite change in the assumptions used for prepayment rates.
(7)
Ranges represent the rates across different yield curves and are presented in basis points. The swap yield curve is utilized among different types of derivatives to project cash flows, as well as to discount future cash flows to present value. Since this valuation methodology uses a range of inputs across a yield curve to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.
(8)
Ranges represent the different correlation factors utilized as components within the valuation methodology. Presenting a range of correlation factors is more representative of the unobservable input used in the valuation. Increases (decreases) in correlation in isolation will increase (decrease) the significance of the change in valuations.
(9)
Represents the risk quoted in basis points of a credit default event on the underlying instrument. The range being provided is a single quoted spread in the valuation model. Credit derivatives with significant unobservable inputs are primarily comprised of written credit default swaps.
(10)
At both September 30, 2013 and December 31, 2012, independent non-binding broker quotations were used in the determination of less than 1% of the total net derivative estimated fair value.
(11)
Ranges represent the underlying equity volatility quoted in percentage points. Since this valuation methodology uses a range of inputs across multiple volatility surfaces to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.
(12)
Changes are based on long U.S. dollar net asset positions and will be inversely impacted for short U.S. dollar net asset positions.
(13)
Mortality rates vary by age and by demographic characteristics such as gender. Mortality rate assumptions are based on company experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
(14)
Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies. For any given contract, lapse rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
(15)
The utilization rate assumption estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible. The rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder. For any given contract, utilization rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
(16)
The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value.
(17)
Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
(18)
Nonperformance risk spread varies by duration and by currency. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative.
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation
The following tables summarize the change of all assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3):
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
Fixed Maturity Securities:
 
U.S.
Corporate
 
Foreign
Corporate
 
Foreign
Government
 
U.S.
Treasury
and Agency
 
RMBS
 
CMBS
 
ABS
 
State and
Political
Subdivision
 
(In millions)
Three Months Ended September 30, 2013:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
$
5,918

 
$
6,008

 
$
1,971

 
$
82

 
$
2,735

 
$
1,050

 
$
3,758

 
$
41

Total realized/unrealized gains (losses)
included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
3

 
5

 
(6
)
 

 
9

 
4

 
3

 

Net investment gains (losses)
4

 
(14
)
 
2

 

 
1

 
(1
)
 
5

 

Net derivative gains (losses)

 

 

 

 

 

 

 

Other revenues

 

 

 

 

 

 

 

Policyholder benefits and claims

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

OCI
(32
)
 
71

 
(42
)
 

 
(16
)
 
22

 
(4
)
 

Purchases (3)
297

 
684

 
209

 

 
563

 
305

 
636

 

Sales (3)
(249
)
 
(273
)
 
(61
)
 
(2
)
 
(138
)
 
(71
)
 
(309
)
 
(1
)
Issuances (3)

 

 

 

 

 

 

 

Settlements (3)

 

 

 

 

 

 

 

Transfers into Level 3 (4)
117

 
173

 
68

 

 

 

 

 

Transfers out of Level 3 (4)
(172
)
 
(390
)
 
(78
)
 
(15
)
 
(136
)
 
(133
)
 
(26
)
 
(24
)
Balance, end of period
$
5,886

 
$
6,264

 
$
2,063

 
$
65

 
$
3,018

 
$
1,176

 
$
4,063

 
$
16

Changes in unrealized gains (losses)
 included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
$
2

 
$
5

 
$
(6
)
 
$

 
$
9

 
$
4

 
$
3

 
$

Net investment gains (losses)
$

 
$
(3
)
 
$

 
$

 
$

 
$

 
$

 
$

Net derivative gains (losses)
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Other revenues
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Policyholder benefits and claims
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Other expenses
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
Equity Securities:
 
FVO and Trading Securities:
 
 
 
Mortgage Loans:
 
Common
Stock
 
Non-
redeemable
Preferred
Stock
 
Actively
Traded
Securities
 
FVO
General
Account
Securities
 
FVO
Contractholder-
directed
Unit-linked
Investments
 
Short-term
Investments
 
Residential
Mortgage
Loans -
FVO
 
Mortgage
Loans Held-
for-sale
 
(In millions)
Three Months Ended September 30, 2013:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
$
183

 
$
408

 
$
11

 
$
46

 
$
593

 
$
344

 
$
150

 
$

Total realized/unrealized gains (losses)
included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income

 

 

 
1

 
(43
)
 
3

 
(2
)
 

Net investment gains (losses)
1

 
(4
)
 

 

 

 
(2
)
 

 

Net derivative gains (losses)

 

 

 

 

 

 

 

Other revenues

 

 

 

 

 

 

 

Policyholder benefits and claims

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

OCI
6

 
11

 

 

 

 
7

 

 

Purchases (3)
6

 
52

 
6

 

 
308

 
106

 
67

 

Sales (3)
(11
)
 
(42
)
 
(1
)
 

 
(232
)
 
(266
)
 

 

Issuances (3)

 

 

 

 

 

 

 

Settlements (3)

 

 

 

 

 

 
(3
)
 

Transfers into Level 3 (4)
1

 

 

 

 

 

 

 

Transfers out of Level 3 (4)
(1
)
 
(20
)
 
(5
)
 

 
(20
)
 

 

 

Balance, end of period
$
185

 
$
405

 
$
11

 
$
47

 
$
606

 
$
192

 
$
212

 
$

Changes in unrealized gains (losses)
 included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
$

 
$

 
$

 
$
1

 
$
(1
)
 
$
2

 
$
(2
)
 
$

Net investment gains (losses)
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Net derivative gains (losses)
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Other revenues
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Policyholder benefits and claims
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Other expenses
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
Net Derivatives: (6)
 
 
 
 
 
 
 
Interest
Rate
 
Foreign
Currency
Exchange
Rate
 
Credit
 
Equity
Market
 
Net
Embedded
Derivatives (7)
 
Separate
Account
Assets (8)
 
Long-term
Debt of
CSEs
 
(In millions)
Three Months Ended September 30, 2013:
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
$
98

 
$
6

 
$
25

 
$
(171
)
 
$
(678
)
 
$
1,225

 
$
(31
)
Total realized/unrealized gains (losses)
included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income

 

 

 

 

 

 

Net investment gains (losses)

 

 

 

 

 
4

 

Net derivative gains (losses)
5

 
3

 
3

 
(85
)
 
888

 

 

Other revenues

 

 

 

 

 

 

Policyholder benefits and claims

 

 

 
5

 
(30
)
 

 

Other expenses

 

 

 

 

 

 

OCI
(11
)
 

 
(1
)
 

 
(16
)
 

 

Purchases (3)

 

 

 

 

 
106

 

Sales (3)

 

 

 

 

 
(84
)
 

Issuances (3)

 

 

 

 

 
51

 

Settlements (3)
(47
)
 
1

 
4

 

 
(217
)
 
(2
)
 
5

Transfers into Level 3 (4)

 

 

 

 

 
162

 

Transfers out of Level 3 (4)

 
(1
)
 

 

 

 
(45
)
 

Balance, end of period
$
45

 
$
9

 
$
31

 
$
(251
)
 
$
(53
)
 
$
1,417

 
$
(26
)
Changes in unrealized gains (losses)
 included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
$

 
$

 
$

 
$

 
$

 
$

 
$

Net investment gains (losses)
$

 
$

 
$

 
$

 
$

 
$

 
$

Net derivative gains (losses)
$
5

 
$
6

 
$
3

 
$
(86
)
 
$
882

 
$

 
$

Other revenues
$

 
$

 
$

 
$

 
$

 
$

 
$

Policyholder benefits and claims
$

 
$

 
$

 
$
6

 
$
(29
)
 
$

 
$

Other expenses
$

 
$

 
$

 
$

 
$

 
$

 
$

 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
Fixed Maturity Securities:
 
U.S.
Corporate
 
Foreign
Corporate
 
Foreign
Government
 
U.S.
Treasury
and Agency
 
RMBS
 
CMBS
 
ABS
 
State and
Political
Subdivision
 
(In millions)
Three Months Ended September 30, 2012:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
$
7,394

 
$
4,813

 
$
2,386

 
$
74

 
$
2,363

 
$
1,038

 
$
2,680

 
$
76

Total realized/unrealized gains (losses)
included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
5

 
5

 
4

 

 
8

 

 
4

 

Net investment gains (losses)
(6
)
 
(13
)
 
6

 

 
(3
)
 
(1
)
 

 

Net derivative gains (losses)

 

 

 

 

 

 

 

Other revenues

 

 

 

 

 

 

 

Policyholder benefits and claims

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

OCI
323

 
135

 
43

 

 
108

 
7

 
32

 
1

Purchases (3)
442

 
630

 
370

 

 
249

 
416

 
215

 
15

Sales (3)
(348
)
 
(276
)
 
(254
)
 

 
(114
)
 
(249
)
 
(47
)
 
(6
)
Issuances (3)

 

 

 

 

 

 

 

Settlements (3)

 

 

 

 

 

 

 

Transfers into Level 3 (4)
128

 
172

 
51

 

 
11

 
26

 
2

 

Transfers out of Level 3 (4)
(239
)
 
(156
)
 
(16
)
 

 
(49
)
 
(23
)
 
(36
)
 
(21
)
Balance, end of period
$
7,699

 
$
5,310

 
$
2,590

 
$
74

 
$
2,573

 
$
1,214

 
$
2,850

 
$
65

Changes in unrealized gains (losses)
 included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
$
3

 
$
5

 
$
5

 
$

 
$
8

 
$

 
$
4

 
$

Net investment gains (losses)
$
(3
)
 
$
(10
)
 
$

 
$

 
$

 
$

 
$

 
$

Net derivative gains (losses)
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Other revenues
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Policyholder benefits and claims
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Other expenses
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
Equity Securities:
 
FVO and Trading Securities:
 
 
 
Mortgage Loans:
 
Common
Stock
 
Non-
redeemable
Preferred
Stock
 
Actively
Traded
Securities
 
FVO
General
Account
Securities
 
FVO
Contractholder-
directed
Unit-linked
Investments
 
Short-term
Investments
 
Residential
Mortgage
Loans -
FVO
 
Mortgage
Loans Held-
for-sale
 
(In millions)
Three Months Ended September 30, 2012:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
$
282

 
$
432

 
$
13

 
$
26

 
$
1,096

 
$
717

 
$

 
$
211

Total realized/unrealized gains (losses)
included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income

 

 

 
7

 
32

 
1

 

 

Net investment gains (losses)
8

 
1

 

 

 

 

 

 

Net derivative gains (losses)

 

 

 

 

 

 

 

Other revenues

 

 

 

 

 

 

 
(23
)
Policyholder benefits and claims

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

OCI
(2
)
 
4

 

 

 

 
15

 

 

Purchases (3)
76

 
1

 
14

 

 
903

 
515

 

 

Sales (3)
(102
)
 
(60
)
 
(11
)
 
(2
)
 
(909
)
 
(337
)
 

 
(145
)
Issuances (3)

 

 

 

 

 

 

 
2

Settlements (3)

 

 

 

 

 

 

 
(10
)
Transfers into Level 3 (4)

 
48

 

 

 
1

 
186

 

 
30

Transfers out of Level 3 (4)

 

 
(2
)
 

 
(2
)
 

 

 
(1
)
Balance, end of period
$
262

 
$
426

 
$
14

 
$
31

 
$
1,121

 
$
1,097

 
$

 
$
64

Changes in unrealized gains (losses)
 included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
$

 
$

 
$

 
$
6

 
$
6

 
$

 
$

 
$

Net investment gains (losses)
$
(1
)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

Net derivative gains (losses)
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Other revenues
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$
(22
)
Policyholder benefits and claims
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Other expenses
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
Net Derivatives: (6)
 
 
 
Interest
Rate
 
Foreign
Currency
Exchange
Rate
 
Credit
 
Equity
Market
 
Net
Embedded
Derivatives (7)
 
Separate
Account
Assets (8)
 
Long-term
Debt of
CSEs
 
MSRs (9)
 
Liability
Related to
Securitized
Reverse
Mortgage
Loans (9)
 
(In millions)
Three Months Ended September 30, 2012:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
$
228

 
$
40

 
$
24

 
$
575

 
$
(3,961
)
 
$
1,445

 
$
(81
)
 
$
564

 
$
(98
)
Total realized/unrealized gains (losses)
included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income

 

 

 

 

 

 

 

 

Net investment gains (losses)

 

 

 

 

 
18

 
7

 

 

Net derivative gains (losses)
(7
)
 
20

 
16

 
(187
)
 
291

 

 

 

 

Other revenues

 

 

 

 

 

 

 
(37
)
 

Policyholder benefits and claims

 

 

 
11

 
(4
)
 

 

 

 

Other expenses

 

 

 

 

 

 

 

 

OCI
(16
)
 

 

 
1

 
(78
)
 

 

 

 

Purchases (3)

 

 

 
7

 

 
144

 

 

 

Sales (3)

 

 

 

 

 
(74
)
 

 

 
97

Issuances (3)

 

 

 

 

 

 

 
4

 

Settlements (3)
12

 
(2
)
 

 
(82
)
 
(170
)
 

 
26

 
(41
)
 
1

Transfers into Level 3 (4)

 

 

 

 

 
2

 

 

 

Transfers out of Level 3 (4)

 

 

 

 

 
(128
)
 

 

 

Balance, end of period
$
217

 
$
58

 
$
40

 
$
325

 
$
(3,922
)
 
$
1,407

 
$
(48
)
 
$
490

 
$

Changes in unrealized gains (losses)
 included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Net investment gains (losses)
$

 
$

 
$

 
$

 
$

 
$

 
$
7

 
$

 
$

Net derivative gains (losses)
$
(4
)
 
$
19

 
$
16

 
$
(195
)
 
$
283

 
$

 
$

 
$

 
$

Other revenues
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$
(24
)
 
$

Policyholder benefits and claims
$

 
$

 
$

 
$
10

 
$
(3
)
 
$

 
$

 
$

 
$

Other expenses
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
Fixed Maturity Securities:
 
U.S.
Corporate
 
Foreign
Corporate
 
Foreign
Government
 
U.S.
Treasury
and Agency
 
RMBS
 
CMBS
 
ABS
 
State and
Political
Subdivision
 
(In millions)
Nine Months Ended September 30, 2013:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
$
7,433

 
$
6,208

 
$
1,814

 
$
71

 
$
2,037

 
$
1,147

 
$
3,656

 
$
54

Total realized/unrealized gains (losses)
included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
10

 
11

 
3

 

 
20

 
2

 
12

 

Net investment gains (losses)
(27
)
 
(34
)
 
8

 

 
4

 
(2
)
 
5

 

Net derivative gains (losses)

 

 

 

 

 

 

 

Other revenues

 

 

 

 

 

 

 

Policyholder benefits and claims

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

OCI
(38
)
 
(97
)
 
(104
)
 
(2
)
 
108

 
(28
)
 
(60
)
 
(1
)
Purchases (3)
824

 
1,364

 
551

 

 
1,155

 
549

 
1,510

 
1

Sales (3)
(907
)
 
(714
)
 
(105
)
 
(4
)
 
(242
)
 
(339
)
 
(651
)
 
(6
)
Issuances (3)

 

 

 

 

 

 

 

Settlements (3)

 

 

 

 

 

 

 

Transfers into Level 3 (4)
324

 
254

 
91

 

 
12

 
113

 

 

Transfers out of Level 3 (4)
(1,733
)
 
(728
)
 
(195
)
 

 
(76
)
 
(266
)
 
(409
)
 
(32
)
Balance, end of period
$
5,886

 
$
6,264

 
$
2,063

 
$
65

 
$
3,018

 
$
1,176

 
$
4,063

 
$
16

Changes in unrealized gains (losses)
 included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
$
9

 
$
10

 
$
3

 
$

 
$
26

 
$
2

 
$
10

 
$

Net investment gains (losses)
$
(34
)
 
$
(3
)
 
$

 
$

 
$
(1
)
 
$

 
$

 
$

Net derivative gains (losses)
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Other revenues
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Policyholder benefits and claims
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Other expenses
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
Equity Securities:
 
FVO and Trading Securities:
 
 
 
Mortgage Loans:
 
Common
Stock
 
Non-
redeemable
Preferred
Stock
 
Actively
Traded
Securities
 
FVO
General
Account
Securities
 
FVO
Contractholder-
directed
Unit-linked
Investments
 
Short-term
Investments
 
Residential
Mortgage
Loans -
FVO
 
Mortgage
Loans Held-
for-sale
 
(In millions)
Nine Months Ended September 30, 2013:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
$
190

 
$
419

 
$
6

 
$
32

 
$
937

 
$
429

 
$

 
$
49

Total realized/unrealized gains (losses)
included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income

 

 

 
6

 
(12
)
 
3

 
(2
)
 

Net investment gains (losses)
2

 
(28
)
 

 

 

 
(24
)
 

 

Net derivative gains (losses)

 

 

 

 

 

 

 

Other revenues

 

 

 

 

 

 

 

Policyholder benefits and claims

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

OCI

 
77

 

 

 

 
15

 

 

Purchases (3)
11

 
55

 
8

 

 
348

 
189

 
214

 

Sales (3)
(15
)
 
(118
)
 

 
(5
)
 
(430
)
 
(414
)
 

 
(45
)
Issuances (3)

 

 

 

 

 

 

 

Settlements (3)

 

 

 

 

 

 

 
(4
)
Transfers into Level 3 (4)
1

 

 

 
14

 
57

 

 

 

Transfers out of Level 3 (4)
(4
)
 

 
(3
)
 

 
(294
)
 
(6
)
 

 

Balance, end of period
$
185

 
$
405

 
$
11

 
$
47

 
$
606

 
$
192

 
$
212

 
$

Changes in unrealized gains (losses)
 included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
$

 
$

 
$

 
$
6

 
$
(5
)
 
$
2

 
$
(2
)
 
$

Net investment gains (losses)
$
(1
)
 
$
(17
)
 
$

 
$

 
$

 
$
(1
)
 
$

 
$

Net derivative gains (losses)
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Other revenues
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Policyholder benefits and claims
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Other expenses
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
Net Derivatives: (6)
 
 
 
 
 
 
 
Interest
Rate
 
Foreign
Currency
Exchange
Rate
 
Credit
 
Equity
Market
 
Net
Embedded
Derivatives (7)
 
Separate
Account
Assets (8)
 
Long-term
Debt of
CSEs
 
(In millions)
Nine Months Ended September 30, 2013:
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
$
177

 
$
37

 
$
43

 
$
128

 
$
(3,162
)
 
$
1,205

 
$
(44
)
Total realized/unrealized gains (losses)
included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income

 

 

 

 

 

 

Net investment gains (losses)

 

 

 

 

 
25

 
(1
)
Net derivative gains (losses)
(23
)
 
(30
)
 
(12
)
 
(390
)
 
3,609

 

 

Other revenues

 

 

 

 

 

 

Policyholder benefits and claims

 

 

 
15

 
(110
)
 

 

Other expenses

 

 

 

 

 

 

OCI
(83
)
 

 

 
(1
)
 
193

 

 

Purchases (3)

 

 

 
4

 

 
249

 

Sales (3)

 

 

 

 

 
(223
)
 

Issuances (3)

 

 

 

 

 
71

 

Settlements (3)
(27
)
 
2

 

 
(7
)
 
(583
)
 

 
19

Transfers into Level 3 (4)

 

 

 

 

 
161

 

Transfers out of Level 3 (4)
1

 

 

 

 

 
(71
)
 

Balance, end of period
$
45

 
$
9

 
$
31

 
$
(251
)
 
$
(53
)
 
$
1,417

 
$
(26
)
Changes in unrealized gains (losses)
 included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
$

 
$

 
$

 
$

 
$

 
$

 
$

Net investment gains (losses)
$

 
$

 
$

 
$

 
$

 
$

 
$
(1
)
Net derivative gains (losses)
$
(14
)
 
$
(28
)
 
$
(11
)
 
$
(390
)
 
$
3,589

 
$

 
$

Other revenues
$

 
$

 
$

 
$

 
$

 
$

 
$

Policyholder benefits and claims
$

 
$

 
$

 
$
15

 
$
(106
)
 
$

 
$

Other expenses
$

 
$

 
$

 
$

 
$

 
$

 
$

 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
Fixed Maturity Securities:
 
U.S.
Corporate
 
Foreign
Corporate
 
Foreign
Government
 
U.S.
Treasury
and Agency
 
RMBS
 
CMBS
 
ABS
 
State and
Political
Subdivision
 
(In millions)
Nine Months Ended September 30, 2012:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
$
6,784

 
$
4,370

 
$
2,322

 
$
31

 
$
1,602

 
$
753

 
$
1,850

 
$
53

Total realized/unrealized gains (losses)
included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
10

 
16

 
4

 

 
20

 
7

 
14

 

Net investment gains (losses)
4

 
(68
)
 
(1
)
 

 
(7
)
 
(37
)
 
2

 

Net derivative gains (losses)

 

 

 

 

 

 

 

Other revenues

 

 

 

 

 

 

 

Policyholder benefits and claims

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

OCI
351

 
233

 
26

 

 
149

 
21

 
19

 
4

Purchases (3)
1,371

 
1,535

 
1,003

 
49

 
1,060

 
695

 
1,293

 
15

Sales (3)
(865
)
 
(708
)
 
(467
)
 
(6
)
 
(315
)
 
(253
)
 
(286
)
 
(7
)
Issuances (3)

 

 

 

 

 

 

 

Settlements (3)

 

 

 

 

 

 

 

Transfers into Level 3 (4)
266

 
254

 
53

 

 
76

 
40

 
6

 

Transfers out of Level 3 (4)
(222
)
 
(322
)
 
(350
)
 

 
(12
)
 
(12
)
 
(48
)
 

Balance, end of period
$
7,699

 
$
5,310

 
$
2,590

 
$
74

 
$
2,573

 
$
1,214

 
$
2,850

 
$
65

Changes in unrealized gains (losses)
 included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
$
8

 
$
18

 
$
12

 
$

 
$
20

 
$
2

 
$
14

 
$

Net investment gains (losses)
$
(6
)
 
$
(27
)
 
$

 
$

 
$
(3
)
 
$
(4
)
 
$

 
$

Net derivative gains (losses)
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Other revenues
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Policyholder benefits and claims
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Other expenses
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
Equity Securities:
 
FVO and Trading Securities:
 
 
 
Mortgage Loans:
 
Common
Stock
 
Non-
redeemable
Preferred
Stock
 
Actively
Traded
Securities
 
FVO
General
Account
Securities
 
FVO
Contractholder-
directed
Unit-linked
Investments
 
Short-term
Investments
 
Residential
Mortgage
Loans -
FVO
 
Mortgage
Loans Held-
for-sale
 
(In millions)
Nine Months Ended September 30, 2012:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
$
281

 
$
438

 
$

 
$
23

 
$
1,386

 
$
590

 
$

 
$
1,414

Total realized/unrealized gains (losses)
included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income

 

 

 
10

 
12

 
1

 

 

Net investment gains (losses)
(1
)
 
1

 

 

 

 

 

 

Net derivative gains (losses)

 

 

 

 

 

 

 

Other revenues

 

 

 

 

 

 

 
(31
)
Policyholder benefits and claims

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

OCI
7

 
23

 

 

 

 
10

 

 

Purchases (3)
111

 
5

 
14

 

 
918

 
1,059

 

 
1

Sales (3)
(126
)
 
(89
)
 

 
(2
)
 
(1,159
)
 
(455
)
 

 
(1,348
)
Issuances (3)

 

 

 

 

 

 

 
6

Settlements (3)

 

 

 

 

 

 

 
(46
)
Transfers into Level 3 (4)
3

 
48

 

 

 
2

 

 

 
72

Transfers out of Level 3 (4)
(13
)
 

 

 

 
(38
)
 
(108
)
 

 
(4
)
Balance, end of period
$
262

 
$
426

 
$
14

 
$
31

 
$
1,121

 
$
1,097

 
$

 
$
64

Changes in unrealized gains (losses)
 included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
$

 
$

 
$

 
$
9

 
$
1

 
$
(1
)
 
$

 
$

Net investment gains (losses)
$
(11
)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

Net derivative gains (losses)
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Other revenues
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$
(25
)
Policyholder benefits and claims
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Other expenses
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
Net Derivatives: (6)
 
 
 
 
 
 
 
 
 
 
 
Interest
Rate
 
Foreign
Currency
Exchange
Rate
 
Credit
 
Equity
Market
 
Net
Embedded
Derivatives (7)
 
Separate
Account
Assets (8)
 
Long-term
Debt of
CSEs
 
MSRs (9)
 
Liability
Related to
Securitized
Reverse
Mortgage
Loans (9)
 
(In millions)
 
 
Nine Months Ended September 30, 2012:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
$
300

 
$
44

 
$
1

 
$
889

 
$
(4,203
)
 
$
1,325

 
$
(116
)
 
$
666

 
$
(1,175
)
Total realized/unrealized gains (losses)
included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income

 

 

 

 

 

 

 

 

Net investment gains (losses)

 

 

 

 

 
95

 
(2
)
 

 

Net derivative gains (losses)
16

 
30

 
44

 
(470
)
 
802

 

 

 

 

Other revenues
(67
)
 

 

 

 

 

 

 
(122
)
 
1

Policyholder benefits and claims

 

 

 
22

 
(9
)
 

 

 

 

Other expenses

 

 

 

 

 

 

 

 

OCI
13

 

 

 
(1
)
 
(39
)
 

 

 

 

Purchases (3)

 

 

 
16

 

 
294

 

 

 

Sales (3)

 

 

 

 

 
(289
)
 

 

 
1,149

Issuances (3)

 

 
(3
)
 

 

 
1

 

 
109

 

Settlements (3)
(45
)
 
(16
)
 
(3
)
 
(131
)
 
(473
)
 
(3
)
 
70

 
(163
)
 
23

Transfers into Level 3 (4)

 

 

 

 

 
25

 

 

 

Transfers out of Level 3 (4)

 

 
1

 

 

 
(41
)
 

 

 
2

Balance, end of period
$
217

 
$
58

 
$
40

 
$
325

 
$
(3,922
)
 
$
1,407

 
$
(48
)
 
$
490

 
$

Changes in unrealized gains (losses)
 included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Net investment gains (losses)
$

 
$

 
$

 
$

 
$

 
$

 
$
(2
)
 
$

 
$

Net derivative gains (losses)
$
2

 
$
10

 
$
43

 
$
(474
)
 
$
781

 
$

 
$

 
$

 
$

Other revenues
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$
(88
)
 
$

Policyholder benefits and claims
$

 
$

 
$

 
$
22

 
$
(7
)
 
$

 
$

 
$

 
$

Other expenses
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

__________________
(1)
Amortization of premium/accretion of discount is included within net investment income. Impairments charged to net income (loss) on securities and certain mortgage loans are included in net investment gains (losses) while changes in the estimated fair value of certain mortgage loans and MSRs are included in other revenues. Lapses associated with net embedded derivatives are included in net derivative gains (losses).
(2)
Interest and dividend accruals, as well as cash interest coupons and dividends received, are excluded from the rollforward.
(3)
Items purchased/issued and then sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements.
(4)
Gains and losses, in net income (loss) and OCI, are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and then out of Level 3 in the same period are excluded from the rollforward.
(5)
Changes in unrealized gains (losses) included in net income (loss) relate to assets and liabilities still held at the end of the respective periods.
(6)
Freestanding derivative assets and liabilities are presented net for purposes of the rollforward.
(7)
Embedded derivative assets and liabilities are presented net for purposes of the rollforward.
(8)
Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders within separate account liabilities. Therefore, such changes in estimated fair value are not recorded in net income. For the purpose of this disclosure, these changes are presented within net investment gains (losses).
(9)
See Note 3 of the Notes to the Consolidated Financial Statements included in the 2012 Annual Report for a discussion of the MetLife Bank Divestiture. See Note 10 of the Notes to the Consolidated Financial Statements included in the 2012 Annual Report for discussion of the valuation techniques and key inputs. Other revenues related to MSRs represent the changes in estimated fair value due to changes in valuation model inputs or assumptions.
Fair Value, Option, Quantitative Disclosures
The following table presents information for certain assets and liabilities accounted for under the FVO. These assets and liabilities were initially measured at fair value.
 
Residential Mortgage Loans — FVO (1)
 
Mortgage Loans Held-for-Sale (2)
 
Certain Assets and Liabilities of CSEs (3)
 
September 30, 2013
 
December 31, 2012
 
September 30, 2013
 
December 31, 2012
 
September 30, 2013
 
December 31, 2012
 
(In millions)
Assets:
 
 
 
 
 
 
 
 
 
 
 
Unpaid principal balance
$
325

 
$

 
$

 
$
80

 
$
2,020

 
$
2,539

Difference between estimated fair value and unpaid principal balance
(113
)
 

 

 
(31
)
 
76

 
127

Carrying value at estimated fair value
$
212

 
$

 
$

 
$
49

 
$
2,096

 
$
2,666

Loans in non-accrual status
$

 
$

 
$

 
$
3

 
$

 
$

Loans more than 90 days past due
$

 
$

 
$

 
$
23

 
$

 
$

Loans in non-accrual status or more than 90 days past due, or both — difference between aggregate estimated fair value and unpaid principal balance
$

 
$

 
$

 
$
(14
)
 
$

 
$

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
Contractual principal balance
 
 
 
 
 
 
 
 
$
1,918

 
$
2,430

Difference between estimated fair value and contractual principal balance
 
 
 
 
 
 
 
 
28

 
97

Carrying value at estimated fair value
 
 
 
 
 
 
 
 
$
1,946

 
$
2,527

__________________
(1)
Interest income, changes in estimated fair value and gains or losses on sales are recognized in net investment income. Changes in estimated fair value for these loans were due to the following:
 
Three Months 
 Ended 
 September 30,
 
Nine Months 
 Ended 
 September 30,
 
2013
 
2012
 
2013
 
2012
 
(In millions)
Instrument-specific credit risk based on changes in credit spreads for non-agency loans and adjustments in individual loan quality
$

 
$

 
$

 
$

Other changes in estimated fair value
(2
)
 

 
(2
)
 

Total gains (losses) recognized in net investment income
$
(2
)
 
$

 
$
(2
)
 
$

(2)
Interest income is included in net investment income. Gains and losses from initial measurement, subsequent changes in estimated fair value and gains or losses on sales are recognized in other revenues. Changes in estimated fair value for these loans were due to the following:
 
Three Months 
 Ended 
 September 30,
 
Nine Months 
 Ended 
 September 30,
 
2013
 
2012
 
2013
 
2012
 
(In millions)
Instrument-specific credit risk based on changes in credit spreads for non-agency loans and adjustments in individual loan quality
$

 
$
(2
)
 
$

 
$

Other changes in estimated fair value

 
(27
)
 

 
71

Total gains (losses) recognized in other revenues
$

 
$
(29
)
 
$

 
$
71

(3)
These assets and liabilities are comprised of commercial mortgage loans and long-term debt. Changes in estimated fair value on these assets and liabilities and gains or losses on sales of these assets are recognized in net investment gains (losses). Interest income on commercial mortgage loans held by CSEs is recognized in net investment income. Interest expense from long-term debt of CSEs is recognized in other expenses.
Estimated fair value of certain investments
The following table presents information for assets measured at estimated fair value on a nonrecurring basis during the periods and still held at the reporting dates; that is, they are not measured at fair value on a recurring basis but are subject to fair value adjustments only in certain circumstances (for example, when there is evidence of impairment). The estimated fair values for these assets were determined using significant unobservable inputs (Level 3).
 
At September 30,
 
Three Months 
 Ended 
 September 30,
 
Nine Months 
 Ended 
 September 30,
 
2013
 
2012
 
2013
 
2012
 
2013
 
2012
 
Carrying Value After
Measurement
 
Gains (Losses)
 
(In millions)
Mortgage loans: (1)
 
 
 
 
 
 
 
 
 
 
 
Held-for-investment
$
232

 
$
379

 
$
(4
)
 
$
(4
)
 
$
13

 
$
9

Held-for-sale
$

 
$
174

 
$

 
$
(10
)
 
$

 
$
(39
)
Other limited partnership interests (2)
$
70

 
$
61

 
$

 
$
(9
)
 
$
(39
)
 
$
(23
)
Real estate joint ventures (3)
$
3

 
$
10

 
$

 
$

 
$
(2
)
 
$
(5
)
Goodwill (4)
$

 
$

 
$

 
$
(1,868
)
 
$

 
$
(1,868
)
__________________
(1)
Estimated fair values for impaired mortgage loans are based on independent broker quotations or valuation models using unobservable inputs or, if the loans are in foreclosure or are otherwise determined to be collateral dependent, are based on the estimated fair value of the underlying collateral or the present value of the expected future cash flows.
(2)
For these cost method investments, estimated fair value is determined from information provided in the financial statements of the underlying entities including NAV data. These investments include private equity and debt funds that typically invest primarily in various strategies including domestic and international leveraged buyout funds; power, energy, timber and infrastructure development funds; venture capital funds; and below investment grade debt and mezzanine debt funds. Distributions will be generated from investment gains, from operating income from the underlying investments of the funds and from liquidation of the underlying assets of the funds. It is estimated that the underlying assets of the funds will be liquidated over the next two to 10 years. Unfunded commitments for these investments at both September 30, 2013 and 2012 were not significant.
(3)
For these cost method investments, estimated fair value is determined from information provided in the financial statements of the underlying entities including NAV data. These investments include several real estate funds that typically invest primarily in commercial real estate and mezzanine debt. Distributions will be generated from investment gains, from operating income from the underlying investments of the funds and from liquidation of the underlying assets of the funds. It is estimated that the underlying assets of the funds will be liquidated over the next one to 10 years. Unfunded commitments for these investments at both September 30, 2013 and 2012 were not significant.
(4)
As discussed in Note 11 of the Notes to the Consolidated Financial Statements included in the 2012 Annual Report, the Company recorded an impairment of goodwill associated with the Retail Annuities reporting unit. This impairment has been categorized as Level 3 due to the significant unobservable inputs used in the determination of the estimated fair value.
Fair value of financial instruments
The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at:
 
September 30, 2013
 
 
 
Fair Value Hierarchy
 
 
 
Carrying
Value
 
Level 1
 
Level 2
 
Level 3
 
Total Estimated
Fair Value
 
(In millions)
Assets:
 
 
 
 
 
 
 
 
 
Mortgage loans:
 
 
 
 
 
 
 
 
 
Held-for-investment
$
55,200

 
$

 
$

 
$
57,639

 
$
57,639

Held-for-sale
225

 

 

 
225

 
225

Mortgage loans, net
$
55,425

 
$

 
$

 
$
57,864

 
$
57,864

Policy loans
$
11,782

 
$

 
$
1,701

 
$
11,900

 
$
13,601

Real estate joint ventures
$
107

 
$

 
$

 
$
177

 
$
177

Other limited partnership interests
$
1,013

 
$

 
$

 
$
1,171

 
$
1,171

Other invested assets
$
855

 
$
234

 
$
276

 
$
345

 
$
855

Premiums, reinsurance and other receivables
$
4,470

 
$

 
$
2,080

 
$
2,466

 
$
4,546

Other assets
$
276

 
$

 
$
211

 
$
94

 
$
305

Liabilities:
 
 
 
 
 
 
 
 
 
PABs
$
140,721

 
$

 
$

 
$
147,010

 
$
147,010

Bank deposits
$

 
$

 
$

 
$

 
$

Long-term debt
$
16,275

 
$

 
$
17,889

 
$

 
$
17,889

Collateral financing arrangements
$
4,196

 
$

 
$

 
$
3,947

 
$
3,947

Junior subordinated debt securities
$
3,193

 
$

 
$
3,738

 
$

 
$
3,738

Other liabilities
$
3,428

 
$

 
$
2,161

 
$
1,270

 
$
3,431

Separate account liabilities
$
62,984

 
$

 
$
62,984

 
$

 
$
62,984

Commitments: (1)
 
 
 
 
 
 
 
 
 
Mortgage loan commitments
$

 
$

 
$

 
$
(14
)
 
$
(14
)
Commitments to fund bank credit facilities, bridge loans and private corporate bond investments
$

 
$

 
$
(1
)
 
$

 
$
(1
)
 
December 31, 2012
 
 
 
Fair Value Hierarchy
 
 
 
Carrying
Value
 
Level 1
 
Level 2
 
Level 3
 
Total Estimated
Fair Value
 
(In millions)
Assets:
 
 
 
 
 
 
 
 
 
Mortgage loans:
 
 
 
 
 
 
 
 
 
Held-for-investment
$
53,926

 
$

 
$

 
$
57,381

 
$
57,381

Held-for-sale
365

 

 

 
365

 
365

Mortgage loans, net
$
54,291

 
$

 
$

 
$
57,746

 
$
57,746

Policy loans
$
11,884

 
$

 
$
1,690

 
$
12,567

 
$
14,257

Real estate joint ventures
$
113

 
$

 
$

 
$
171

 
$
171

Other limited partnership interests
$
1,154

 
$

 
$

 
$
1,277

 
$
1,277

Other invested assets
$
815

 
$
305

 
$
144

 
$
366

 
$
815

Premiums, reinsurance and other receivables
$
3,287

 
$

 
$
745

 
$
2,960

 
$
3,705

Other assets
$
260

 
$

 
$
214

 
$
78

 
$
292

Liabilities:
 
 
 
 
 
 
 
 
 
PABs
$
149,928

 
$

 
$

 
$
158,040

 
$
158,040

Bank deposits
$
6,416

 
$

 
$
2,018

 
$
4,398

 
$
6,416

Long-term debt
$
16,502

 
$

 
$
18,978

 
$

 
$
18,978

Collateral financing arrangements
$
4,196

 
$

 
$

 
$
3,839

 
$
3,839

Junior subordinated debt securities
$
3,192

 
$

 
$
3,984

 
$

 
$
3,984

Other liabilities
$
1,913

 
$

 
$
673

 
$
1,243

 
$
1,916

Separate account liabilities
$
58,726

 
$

 
$
58,726

 
$

 
$
58,726

Commitments: (1)
 
 
 
 
 
 
 
 
 
Mortgage loan commitments
$

 
$

 
$

 
$
12

 
$
12

Commitments to fund bank credit facilities, bridge loans and private corporate bond investments
$

 
$

 
$
22

 
$

 
$
22

__________________
(1)
Commitments are off-balance sheet obligations. Negative estimated fair values represent off-balance sheet liabilities. See Note 15 for additional information on these off-balance sheet obligations.